INTRODUCTION: We report on a severely injured trauma patient who suffered a high velocity motorcycle accident. The patient was receiving dual antiplatelet therapy with aspirin and clopidogrel. METHODS AND RESULTS: Thromboelastometry (ROTEM(®)) on admission revealed low maximum clot firmness (MCF) in the FIBTEM assay, strongly indicating impaired fibrin polymerization. Inhibition of platelet activity also was confirmed. Massive intra-abdominal bleeding caused by a liver rupture required immediate laparotomy. Haemostasis during emergency surgery was achieved through topical surgical measures and intravenous fibrinogen concentrate administration (three doses of 4 g), guided by ROTEM test results only. As platelet count decreased to 28 × 10(9) L(-1), 6 h after admission to the intensive care unit, the patient received two units of platelet concentrate. No further haemostatic therapy was necessary during the next 48 h. CONCLUSION: This case shows the potential effectiveness of fibrinogen concentrate in improving haemostasis in trauma patients receiving antiplatelet therapy.
INTRODUCTION: We report on a severely injured traumapatient who suffered a high velocity motorcycle accident. The patient was receiving dual antiplatelet therapy with aspirin and clopidogrel. METHODS AND RESULTS: Thromboelastometry (ROTEM(®)) on admission revealed low maximum clot firmness (MCF) in the FIBTEM assay, strongly indicating impaired fibrin polymerization. Inhibition of platelet activity also was confirmed. Massive intra-abdominal bleeding caused by a liver rupture required immediate laparotomy. Haemostasis during emergency surgery was achieved through topical surgical measures and intravenous fibrinogen concentrate administration (three doses of 4 g), guided by ROTEM test results only. As platelet count decreased to 28 × 10(9) L(-1), 6 h after admission to the intensive care unit, the patient received two units of platelet concentrate. No further haemostatic therapy was necessary during the next 48 h. CONCLUSION: This case shows the potential effectiveness of fibrinogen concentrate in improving haemostasis in traumapatients receiving antiplatelet therapy.
Authors: Lucy Z Kornblith; Matthew E Kutcher; Brittney J Redick; Carolyn S Calfee; Ryan F Vilardi; Mitchell Jay Cohen Journal: J Trauma Acute Care Surg Date: 2014-02 Impact factor: 3.313
Authors: Rolf Rossaint; Bertil Bouillon; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Daniela Filipescu; Beverley J Hunt; Radko Komadina; Giuseppe Nardi; Edmund A M Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Jean-Louis Vincent; Donat R Spahn Journal: Crit Care Date: 2016-04-12 Impact factor: 9.097
Authors: Christoph J Schlimp; Anna Khadem; Anton Klotz; Cristina Solomon; Gerald Hochleitner; Martin Ponschab; Heinz Redl; Herbert Schöchl Journal: J Trauma Acute Care Surg Date: 2015-04 Impact factor: 3.313
Authors: Mark Walsh; Stephanie Fritz; Daniel Hake; Michael Son; Sarah Greve; Manar Jbara; Swetha Chitta; Braxton Fritz; Adam Miller; Mary K Bader; Jonathon McCollester; Sophia Binz; Alyson Liew-Spilger; Scott Thomas; Anton Crepinsek; Faisal Shariff; Victoria Ploplis; Francis J Castellino Journal: Curr Drug Targets Date: 2016 Impact factor: 3.465
Authors: Christoph J Schlimp; Wolfgang Voelckel; Kenji Inaba; Marc Maegele; Herbert Schöchl Journal: Scand J Trauma Resusc Emerg Med Date: 2013-10-08 Impact factor: 2.953